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Background: Jatropha curcas (JCP1), Pyrenacantha staudtii (PS), Picralima nitida (ZI) and Jatropha gossypifolia (JCP2)
are plants used in the African folklore for the treatment of various cancers.
Methods: This study investigated the in vitro anticancer effects of the ethanol extracts against human epithelial
MCF-7 breast cancer cells in a dose-dependent manner (1–50 μg/ml) by using cell cycle analysis, viability assay,
annexin V/PI staining, TUNEL method and expression determination of apoptotic and adhesion relevant proteins.
Adhesion processes were monitored by detachment via flow cytometry, β1-integrin expression and formation of
the actin cytoskeleton.
Results: The three extracts, termed PS, JCP1 and JCP2 at a concentration of 10 μg/ml induced cell death in MCF-7
breast cancer cells verified by high amounts of PI-positive cells in the cell cycle analysis, Annexin V/PI staining and
DNA fragmentation measurements. In parallel cell detachment was accompanied by decreased β1- integrin
expression and phosphorylation of the focal adhesion kinase at Tyr397. ZI extract was the exception by the increasing
β1-integrin expression and strengthening the cortical actin cytoskeleton. However, all four plant extracts mediated
strong anti-cancer properties with IC50 values between 23–38 μg/ml.
Conclusion: PS, JCP1 and JCP2 were found to be very active against MCF-7 cells by inducing anoikis and therefore
possessing vast potential as medicinal drugs especially in estrogen receptor positive breast cancer treatment. ZI
mediated their anti-cancer action by different signaling mechanisms which should be analyzed in future studies.
Our results further supported the idea that medicinal plants can be promising sources of putative anticancer agents.
Keywords: Traditional medicine, Breast cancer, Plant extraction, Cell cycle, Apoptosis, Integrin, Adhesion, AnoikisBackground
The use of natural products including medicinal plants
has become more and more important in primary health
care especially in developing countries. Many pharma-
cognostical and pharmacological investigations are carried
out to identify new drugs or to find new lead structures to
develop novel therapeutic agents for the treatment of
human diseases such as cancer [1]. In developing
countries and particularly in Yemen, a large segment
of the population still rely on folk medicine to treat* Correspondence: faloabi@uniben.edu
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rent types of inflammations.
Currently, there is insufficient scientific research on the
plants from Nigeria. Previous studies described the anti-
cancer investigations of some endemic and non-endemic
plants from Nigeria [2]. This study was carried out as a
part of our continued exploration of Nigerian medicinal
plants for interesting biological activities. Thus, the main
aim of the present project was to carry out a phytoche-
mical and cell biological investigation on selected plants
from the southern part of Nigeria, especially on those that
are endemic and those that find a use in traditional medi-
cine as anticancer agents. In this study, four plants were
collected for evaluation of their antitumor activities with
respect to pro-apoptotic and anti-adhesive properties.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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plant family: Apocynaceae) has widely varied applications
in Nigeria folk medicine for antipyretic, antihypertensive,
gastro-intestinal disorders, as an antimalarial, aphrodis-
iac, antitrypanocidal, and as a remedy against hypergly-
cemia [3-6]. The plant is used in Nigeria and West
Africa as remedy against breast cancer [7].
Pyrenacantha staudtii Hutch and Dalz (Tropical forest
tree family: Icacinaceae) is a medicinal plant widely used in
tropical Africa for the treatment of various ailments such
as stomach disorders, intestinal colic, menstrual disorders,
and as anticancer and antiabortificient agents [8,9].
Jatropha gossypifolia L (Euphorbiaceae) is widely dis-
tributed in many tropical countries [10,11]. It has anti-
bacterial, antiinflammatory, analgesic and anticancer
activities [12]. It was known in ancient medicine for its
ethnomedicinal uses in the treatment of cancerous
growth and for its pesticidal activity [13,14].
Jatropha curcas Linnaeus (Euphorbiaceae) is a small tree
or large shrub that can reach a height up to 5 m. It is used
in traditional medicine as remedy against cough, cancer,
and human immunodeficiency virus [15]. The local popu-
lace in the eastern part of Nigeria uses the ethanol extract
for the treatment of breast cancer. In some cases, trad-
itional herbal practitioners use the aqueous decoction to
cure cancer [15]. The search for anticancer agents via ac-
tivity directed identification and characterization lead to
the present study with a view to validating the claimed
ethno-medicinal property of these plants as anticancer
remedy. Hence, this study is focused totally on the expos-
ure of the ethanol root bark extracts of the plants to
MCF-7 cancer cell line in a dose-dependent manner.
Methods
Collection and identification of plant materials
The plant parts (listed in Table 1) were collected from
different locations of Nigeria in the rainy season
(March-June) of 2011 and identified by Mr. A. Sunny of
the Department of Pharmacognosy, Faculty of Pharmacy,
University of Benin, Benin City. Voucher specimens
are deposited at the Faculty of Pharmacy, University of
Benin, Nigeria.Table 1 Properties of the four Nigerian plants used in this stu
Plant Abbr. Family Parts
used
M
*Jatropha curcas Linn JCP1 Euphorbiaceae RB co
*Pyrenacantha staudtii Hutch &
Dalz
PS Icacinacaeae L th
ca
*Picralima nitida Th. & H. Durand ZI Apocynaceae RB m
*Jatropha gossypifolia Linn JCP2 Euphorbiaceae RB ca
Overview of the four plant extracts including its medical uses, IC50 values at 48 h fo
has been taken from native people.Preparation of plant extracts
The powdered plant samples (100 g) were each extracted
by maceration, with ethanol (250 ml) at room temperature,
and concentrated to dryness using a rotary evaporator at
reduced pressure. The% yield (10, 23, 40 and 51 for JCP1,
PS, ZI and JCP2, respectively) was obtained. Dried samples
were stored at −20°C until further use. Finally, all plant ex-
tracts were dissolved in dimethylsulfoxide (DMSO) to give
a desired stock solution of 50 mg/ml, which was aliquoted
and stored at −80°C.
Phytochemical composition of extracts
The ethanol extracts were subjected to photochemical
screening in order to identify the secondary metabolites
and nature of the extracts. The method employed, was
from Trease and Evans [16].
Cell culture
Human breast adenocarcinoma cell line MCF-7 (ATCC no.
HTB-22) was obtained from the America Type Culture
Collection (Manassas VA, USA). Cells were maintained at
37°C and in a 5% CO2 atmosphere in a monolayer in Dul-
becco’s modified Eagle’s medium (DMEM, Invitrogen,
Germany) with 10% fetal bovine serum (PAA Laboratories
GmbH, Germany) and 1% gentamycin (Ratiopharm,
Germany). Confluent cells were passaged by treating
them with 0.05% trypsin/ 0.02% EDTA. The medium was
changed every two days. MCF-7 cells were authenticated by
morphology and growth rate and were mycoplasma free.
Cultivation conditions were described previously [17].
Treatment with plant extracts
Treatment conditions were previously described [17].
Treatments with the four plant extracts (final concen-
trations of 1, 10, 25, 50 μg/ml) were carried out for
48 h in assay medium. As negative control substance
the vehicle dimethylsulfoxide (DMSO, 0.1%) was used
in the same manner.
Cell cycle analysis
To determine proliferation and apoptosis alterations, the
cell cycle analysis via flow cytometry (FACSCalibur, BDdy
edical uses Location IC50 MCF-7 (μg/
ml)
ugh, wound healing, HIV, cancer Benin
City
36.55





alaria, hyperglyaceamia, antiseptic etc. NIFOR 22.76
ncer, pesticides Owan 25.55
r MCF-7 cells. RB; Root bark; L; leaf; * Most of the information of traditional use
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of the MCF-7 cells was carried out [17,18]. For data ac-
quisition, the software FlowJo version 7.6.5 (Tree Star;
www.flowjo.com) was used. A minimum of 15,000
ungated events were recorded. For statistical analysis,
the S-phase and G2/M-phase cells of the cell cycle were
defined as proliferative cells and the sub-G1-peak of the
histogram as apoptotic ones.
Annexin V/PI apoptosis detection
In this assay, Annexin-V detects the translocation of
phosphatidylserine from the inner leaflets to the outer
leaflets of the plasma membrane, which is a key feature
of apoptotic cells, whereas PI detects necrotic cells with
permeabilized plasma membrane. Labeling of early
apoptotic and dead cells was performed according to the
manufacturer's instructions from the Alexa Fluor488
Annexin V/Dead Cell Apoptosis Kit (Thermo Fisher
Seintific Inc., Germany). Cells were treated with 10 μg/ml
plant extract for 48 h. After treatment detached as well as
adherent cells were washed twice with cold PBS. The cell
pellet was resuspended in 100 μl of annexin binding buffer
at a density of 1 × 106 cells per ml and incubated with 5 μl
of Alexa488-conjugated Annexin-V and 5 μl of PI for
15 min at room temperature in the dark. 400 μl of 1×
binding buffer was added to each sample tube, and the
samples were immediately analyzed by flow cytometry.
Histograms and statistics were designed with the software
FlowJo Version 7.6.5.
Calculation of cell detachment
400,000 MCF-7 cells were seeded in 6-well plates (Greiner,
Germany). After treatment with the four plant extracts
(10 μg/ml) and the DMSO control detached cells were
counted by flow cytometry.
Measurement of integrin expression
Measurement and calculation of β1-integrin expression
at the cell surface by flow cytometry (FACSCalibur) was
described previously [18]. Anti-integrin antibody β1
(CD29; Immunotech, 0.2 mg/ml, mouse anti-human
4B4, Isotype: IgG1) was secondarily labeled with fluores-
cein isothiocyanate-conjugated anti-mouse IgG (Fab2)
fragment (Sigma). Ten thousand events were recorded
for each measurement and each measurement was re-
peated three times.
Immunofluorescence and microscopy
Filamentous (F)-actin was selectively labeled with BOD-
IPY® FL phallacidin emitting green fluorescence (Invitro-
gen, Germany). Nuclei were stained with Hoechst dye
(Invitrogen, Germany). Bright field and all fluorescence
images were obtained using Axio Scope A1 fluorescence
microscope (Carl Zeiss, Germany). Individual fluorophoreswere imaged in black and white for maximum sensitivity
and pseudocolored and overlaid using AxioVision Imaging
Software Release 4.8.2. (Carl Zeiss, Germany).Western blotting procedure
After treatment with the plant extracts for at least 48 h
the cells were trypsinized, washed with PBS and lysed in
ice-cold lysis buffer (Bio-Plex Cell Lysis Kit, Bio-Rad,
USA). Cells were homogenized by brief sonification at 4°
C and centrifuged at 10,000 g for 2 min at 4°C. Protein
concentrations of the supernatants were estimated by
Bradford protein assay so that equal amounts (10 μg) of
total soluble protein could be separated by Criterion
TGX Stain-Free precast gels (Bio-Rad, Germany) and
blotted on PVDF membranes. After SDS-PAGE, protein
content per lane as well separation quality was addition-
ally controlled with the Criterion Stain FreeTM gel im-
aging system (Bio-Rad, Germany). After the protein
transfer membranes were blocked with 5% skim milk in
Tris buffered saline (TBS) and washed six times in TBS.
For protein detection primary antibodies (β1 integrin: sc-
374429; PCNA: sc- sc-56; both from Santa Cruz, USA;
caspase 7, 8, 9 from the Apoptosis sampler kit #9915; FAK
antibodies within the sampler kit #9330; Akt #4691; pAkt
(S473) #9271; p44/42 MAPK #9102; P-p44/42 MAPK
(T202/204) #4377; β-Actin #4970: all from Cell Signaling,
USA) were incubated overnight at 4°C followed by labeling
with a horseradish peroxidase (HPR)-conjugated secondary
antibody (Dako, Glostrup, Denmark) for 1 hour at room
temperature. Protein signals were visualized by using
SuperSignal West Femto Chemiluminescent Substrate
(Pierce Biotechnology, Rockford, USA) for detection of
peroxidase activity from HRP-conjugated antibodies
(Thermo Fisher Scientific Inc., Rockford, USA). Band
intensity was analyzed densitometrically with the Mo-
lecular Imager ChemiDoc XRS and Image Lab 3.0.1
software (Bio- Rad, USA). Protein detection was re-
peated at least three times with individual prepared cell
lysates from independent passaged cells.Tunel assay
Apoptotic DNA degradation was stained using the ter-
minal deoxynucleotidyl transferase (TdT)-mediated
dUDP-biotin nick end labeling (TUNEL) method. In this
study, the In Situ Cell Death Detection Kit, Fluorescein
(Roche, USA) was used for this purpose according to the
manufacturer’s protocol. Briefly, MCF-7 cells (1.5 × 106
cells/well) were cultured on cover glasses in 6-well
plates. After exposure to the plant extracts, cells were
washed with PBS, fixed with 4% paraformaldehyde solu-
tion for 1 h at 15–25°C, and incubated in permeabilisa-
tion solution for 2 min on ice. After washing with PBS
cells were incubated with the TUNEL reaction mixture











Alkaloids + + + -
Saponins + + + -
Tannins + + + +
Flavonoids + + + +
Phytochemical compositions of the root bark extracts of four medicinal
plants. + presence of components; − absence of components.
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dark.
Fluorescence of the stained cells was observed using a
Carl-Zeiss confocal laser scanning microscope (LSM
780, Jena, Germany) with an excitation wavelength of
488 nm.
Calculation of IC50 values
The half maximal inhibitory concentrations (IC50) values
were calculated by colorimetric measurements of mito-
chondrial metabolic activity with the CellTiter MTS/PES
assay following to the manufacturer’s instructions (Promega
Corp., Madison, WI). MTS is a tetrazolium compound
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium] which is combined
with an electron coupling reagent (phenazine ethosul-
fate; PES) to form a stable solution. The conversion to
formazan is bioreduced by cells which is presumably
accomplished by NADPH or NADH produced by de-
hydrogenase enzymes in metabolically active cells. The
measured mitochondrial metabolic activity also reflects the
cell cytotoxicity directly and the cell viability indirectly.
Cells were seeded in 96-well plates at a density of 2000
cells/well in 100 μl medium and left to attach for 24 h.
Treatment with plant extracts at final concentrations of
1, 10, 25, and 50 μg/ml was carried out as described pre-
viously. In parallel, control approaches were carried out
with medium only and 0.1% of the solvent DMSO to cal-
culate background absorbance. No background absorb-
ance was obtained for the extracts and MTS in the
absence of cells, as some extracts are capable of reducing
the MTS. After an initial incubation for 24 h cells were
assayed with MTS according to the manufacturer’s in-
structions (Promega Corp., Madison, WI). Colorimetric
changes were measured at 490 nm and raw data was
transferred to Microsoft Excel and analyzed. At least 8
replicates corrected with the background absorbance were
performed. Reduction of cell viability at each concentra-
tion was plotted as a dose response curve. The IC50 of the
active extracts were calculated using nonlinear regression
to fit data to the dose–response.
Live/dead cell staining
Live/Dead cell staining was performed following the
manufacturer's instructions (Live/Dead Cell Staining Kit
II, PromoCell GmbH, Germany).
Statistical analysis
All data were analyzed by the Students t-test using
Microsoft Excel 2010. Every experiment was done in
triplicate with individual passaged cells and data sets
were expressed as means ± standard deviations (SD).
Statistical significance was represented as ***P < 0.001,
**P < 0.01, *P < 0.05.Results and discussion
The list of the investigated plants, the parts used and
their known medicinal uses are represented in Table 1.
These informations were sorted out in accordance with the
recommendation of the Handbook of African Medicinal
Plants [4]. Ethnobotany Desk Reference [19], and direct
information obtained by Dr. A. Falodun (Department
of Pharmaceutical Chemistry, Faculty of Pharmacy,
University of Benin, Benin City, Nigeria) through inter-
viewing local traditional healers. Ethno pharmacological
data (information based on the medicinal traditional
use of plants) has been one of the common useful ways
for the discovery of biologically active compounds
from plants [20]. The phytochemical composition of
the extracts showed the presence of alkaloids, tannins,
saponins, flavonoids in JCP1, PS and ZI. Only tannins
and flavonoids were present in JCP2 (Table 2).
Proliferation and apoptosis events after treatment with
the plant extracts
First, the anti-cancer properties of these four extracts were
examined by cell cycle analysis. Therefore, we chose the
breast cancer cell line MCF-7, a model for hormone-
dependent non-invasive cancer types. This model fits for
initial screening experiments with these untested extracts.
Cell cycle analysis via flow cytometry allowed us to distin-
guish between alterations in proliferation and apoptosis.
Distribution of cell cycle phases (histograms) of MCF-7
cells after treatment with different concentrations (1, 10,
25 and 50 μg/ml) of the plant extract are mentioned in
Figure 1A. In untreated, exponentially growing MCF-7
cells the G1- and G2/M-phases were well defined with a
large number of dividing cells (S-phase between G1- and
G2/M-peaks). Demonstrated were the most prominent
histograms of all measurements (Figure 1A).
All four plant extracts caused a significant influence
on the proliferation phases of the MCF-7 cells, which
turned out to be concentration dependent but not al-
ways linear. To quantify proliferation we defined the cell
cycle phases S and G2/M as proliferative phases so that
the sum of it describes the proliferation rate. In parallel,
the apoptotic rates were measured by determination of
Figure 1 (See legend on next page.)
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Figure 1 Cell cycle analysis of MCF-7 cells. A: Histograms of the cell cycle distribution of MCF-7 cells after treatment with the control substance
DMSO and the plant extracts JCP1, PS, ZI, JCP2 at concentrations of 1, 10, 25 and 50 μg/ml for 48 hours. G1, S and G2/M phases are marked
with black arrows. Represented were the most prominent samples of 3–5 individual replicates. B: Calculation of proliferation and sub-G1 phase.
Measurement of proliferation and apoptosis via cell cycle analysis after treatment with the vehicle DMSO (equates to 100%) and the plant extracts
JCP1, PS, ZI, JCP2 at concentrations of 1, 10, 25 and 50 μg/ml for 48 h. As proliferative phases the sum of S and G2/M phases were calculated in
percentages. As apoptotic fraction the sub G1-peak was measured. (mean ± SD, n = 5, ***P < 0.001, **P < 0.01, *P < 0.5, significantly different
compared to control, unpaired t-test).
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Both results were displayed in Figure 1B. As negative
control the DMSO treated cells were set to 100%. As
positive controls genistein was used which results were
previously reported [17]. Only the PS extract mediated
an almost linear reduction in proliferation. In contrast,
the ZI extract showed a biphasic effect. Low concentra-
tions (1–10 μg/ml) caused an increase in the prolife-
rative phases and at a concentration >25 μg/ml, the
proliferation was significantly reduced. JCP1 inducedFigure 2 Apoptosis determination via Annexin V/PI staining. A: Hist
10 μg/ml of the four plant extracts in comparison with the control treat
to distinguish early apoptotic (Annexin V- positive, PI negative; quadran
positive, PI positive; quadrant 2 of each panel). B: Table of quantitative a
MCF-7 cells. Notably, sub-G1 phase positive cells from the cell cycle mea
three separate experiments.only a slight proliferation induction after an exposure of
25 μg/ml accompanied by a significant elevation of sub-
G1 positive cells. This effect of proliferation and apop-
tosis induction at the same time is noted by a number of
studies have which have shown that cell-cycle regulators
could interconnect with proliferation and apoptosis
[21]. In contrast, JCP2 displayed a bi-phasic effect on
the distribution of the MCF-7 cell cycle phases. At the
lowest concentration of 1 μg/ml the content of the G2/
M phase nearly doubled in comparison to the DMSOogramms of Annexin V/PI- stained MCF-7 cells after treatment with
ment for 48 h. Annexin V in conjunction with PI staining was used
t 1 of each panel) from late apoptotic or necrotic cells (Annexin V
nalysis of single Annexin V or PI positive and double positive stained
surement were listed for comparison. Results are representative of
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tration of 10 μg/ml caused also a significant reduction
of G2/M phase and an arrest in G0/G1 phase.
But ultimately, all four extracts mediate a significant
increase in sub-G1 phase. The extracts JCP1 and JCP2,
already caused at the low concentration of 10 μg/ml a
significant increase in the sub-G1 phase. In summary, all
four plant extracts were able to influence the prolifera-
tion rates of the estrogen receptor-positive cell line
MCF-7 depending on the concentrations used. This
phenomenon is not uncommon for some effective anti-
cancer extracts. For example, soy ingredients like genistein
causes biphasic effects on hormone-dependent cancer cell
lines [22]. At low concentrations (1–10 μM), genistein
stimulates cell proliferation whereas higher concentrations
are able to induce a block in G2/M phase. This result sug-
gests that the plant extracts contain substances that trig-
ger similar biphasic effects, known as phytoestrogens such
as genistein. In subsequent experiments, the exact in-
gredients of the extracts by high-performance liquid
chromatography (HPLC) and gas chromatography–
mass spectrometry (GC-MS) will be analyzed to obtain
a deeper insight into the existing drug classes.
However, to confirm the results of the cell cycle ana-
lysis, three additional methods were used to verify theFigure 3 Protein expression analysis of MCF-7 cells by Western blotti
comparison with the control treatment for 48 h. A: Determination of ca
as the cleaved proteins. B: Expression of total focal adhesion kinase (FAK) p
content of kinases: total Akt, phosphorylated Akt at residue S473 (pAkt), tot
(P-p44/42) and β-Actin which did not function as housekeeping protein. D
protein amounts on each polyacrylamide gel used.influence on proliferation and apoptosis: Annexin V/PI
labeling, TUNEL assay and western blotting experiments
of relevant proteins. Beside the calculation of the sub-G1-
peak by cell cycle analysis, apoptosis/necrosis induction
was determined by using Alexa Fluor488 Annexin V/PI
staining (Figure 2). Treatment with 10 μg/ml JCP1 and
JCP2 resulted in the highest levels of dead MCF-7 cells
(46% and 47%) which were positive for the PI labeling.
These values are comparable with the apoptosis data ob-
tained from the determination of the sub-G1 phase in the
cell cycle measurement which indeed showed the highest
percentages in sub-G1 phase. The treatment with 10 μg/
ml PS and ZI resulted in approximately 33% cell death
compared to the control. Surprisingly, only the treatment
with 10 μg/ml ZI showed a moderate Annexin V/PI label-
ing, as an indication of late apoptosis induction. PS, and
especially JCP1 and JCP2 induced only necrotic events,
verified by high amounts of PI-positive cells. These re-
sults are similar to those of the TUNEL measurements
(Additional file 1: Figure S1). At concentrations of
10 μg/ml PS, JCP1 as well as JCP2 caused DNA fragmenta-
tion within the cell nucleus, whereas ZI induced signals
within the cytoplasm, indicating for extrinsic death signals.
Furthermore, the induction of apoptosis was verified
by western blot analysis with apoptosis relevant specificng after treatment with 10 μg/ml of the four plant extracts in
spase 7, 8, and 9 cleavage. Detected were the pro-caspases as well
rotein and phosphorylated FAK protein at residue Tyr397. C: Protein
al MAPK p44/42, phosphorylated MAPK p44/42 at residues T202/204
: Stain-free image of separated proteins after SDS-PAGE to ensure equal
Figure 4 (See legend on next page.)
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Figure 4 Measurement of cell detachment and morphological alterations. A: Cell detachment was calculated by flow cytometry after 48 h
after exposure to 10 μg/ml of the plant extracts and 0.1% DMSO. (mean ± SD, n = 8, **P < 0.01, *P < 0.05, significantly different compared to control,
unpaired t-test). B: Bright field microscopy to monitor morphological alterations after treatment with the four plant extracts JCP1, PS, ZI, JCP2 in a
concentration dependent manner on MCF-7 cells. Even the lowest concentration of 1 μg/ml caused a significant detachment of the MCF-7 cells from
the plate surface. At a concentration of 10 μg/ml almost 70 - 80% of all cells treated with PS, JCP1 and JCP2 were detached. Detachment correlates
with induction of apoptosis which was determined by two-color fluorescent Live/Dead-Staining. Green: viable cells; red: dead cells.
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JCP1 and JCP2 revealed a cleavage of caspase 7 and
caspase 9 so that pro-caspases 7 and 9 were hardly to de-
tect which also applies also to caspase 8. Interestingly, nei-
ther the PS nor the ZI extract lead to caspase cleavage.
The proliferation results of the cell cycle analysis were val-
idated by the expression analysis of PCNA (Proliferating
Cell Nuclear Antigen) (Additional file 2: Figure S2). At a
concentration of 10 μg/ml ZI induced an increase of the
proliferative phases whereas the JCP1 and JCP2 decreased
the expression of PCNA. Ultimately, these results demon-
strate that the cell cycle analyses were well performed and
comparable with Annexin V/PI labeling as well as with ex-
pression analysis of PCNA. The JCP1 and JCP2 extracts
mediated the strongest decrease in proliferation with a
simultaneous induction of cell death.
Plant extracts induced cell detachment mediated by
decreased β1 integrin expression
Morphological alterations under treatment conditions
were verified by bright field microscopy (Figure 4B). The
plant extracts PS, JCP1 and JCP2 at concentration of
10 μg/ml or higher induced a loss of cell-cell and cell-
matrix adhesion accompanied by rounding of the cells.
Treatment with ZI induced no visual cell detachment.
Incubation with 1 μg/ml plant extract resulted in a few
detached cells while the typical cell cluster of MCF-7,
called domes, were not affected. To calculate detach-
ment rates, detached MCF-7 cells after exposure to
10 μg/ml plant extract were counted by flow cytometry
(Figure 4A). The extracts JCP1 and JCP2 induced signifi-
cant increased cell detachment with rates of 81% and
76%, respectively. Exposure with the PS extract resulted
in 59% detached cells. The ZI extract caused no signifi-
cant cell detachment in comparison to the control.
Detachment from the extracellular matrix or lost con-
tact with the neighbor cells is a clear indication of induc-
tion of an apoptotic process that is termed anoikis [23].
This observation confirmed the results of the cell cycle
measurements that showed a significant increase of apop-
totic cells after treatment with 50 μg/ml of the four plant
extracts. To confirm the induction of anoikis, which is
accompanied by cell detachment, we performed live/
dead staining of the cell after exposure to 10 μg/ml of
the extracts. These staining demonstrated that only at-
tached cells were viable (green fluorescence) whiledetachment by the extracts caused cell death (red fluo-
rescence). Moreover, this test showed that the concen-
tration of 10 μg/ml of each extract led to a different
degree of cell detachment. Treatment with JCP1 and
JCP2 resulted in the highest cell detachment rates (ap-
proximately 60 - 90%), so that nearly no viable cells
were attached to the cell culture plates. The ZI extract
exhibited the lowest rate of cell detachment and only a
few dead cells, which correlated with the results of the
cell cycle measurements where the ZI extract at a con-
centration of 10 μg/ml showed a significantly increased
proliferative phase.
The ability of epithelial cells to survive through sup-
pression of anoikis depends on their engagement to the
extracellular matrix through a family of heterodimeric
transmembrane receptors named integrins. Anoikis in
mammary epithelial cell can be initiated by direct inhib-
ition of β1-integrins [24,25]. Therefore, the β1 integrin
expression by flow cytometry analysis was measured
(Figure 5A). Although the three plant extracts, JCP1,
JCP2 and PS lead to cell detachment at a concentration
of 10 μg/ml, only JCP2 lowered the β1-integrin expres-
sion in MCF-7 cells, significantly. PS and JCP1 revealed
only a slight decrease in β1-integrin expression while ZI
increased the β1-integrin level significantly up to 9%. Be-
cause the flow cytometry data only represent the levels
of membrane associated β1-integrin expression, western
blotting was performed with a β1-integin specific anti-
body. Additional file 2: Figure S2 shows the expression
pattern of β1-integrin in the soluble and membrane pro-
tein fractions. Consistent with flow cytometry results the
exposure with 10 μg/ml ZI revealed a significant in-
crease of β1-integrin in the membrane fraction, while
the soluble content was markedly reduced. The extracts
JCP1 and JCP2 convey no significant change in β1-
integrin expression, neither in the soluble nor the mem-
brane fraction. The PS extract is the exception. Com-
pared with the flow cytometry data 10 μg/ml PS extract
caused a significant increase in β1-integrin expression in
the membrane fraction while the soluble protein content
was reduced. This phenomenon may be attributable to
the fact that different antibodies were used for the flow
cytometry analysis. The antibody suitable for western
blotting detection of β1-integrin was raised against
amino acids 375–480 mapping within an extracellular
domain of β1-integrin of human origin (sc-374429,
Figure 5 (See legend on next page.)
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Figure 5 Monitoring of adhesion related proteins. A: Cell membrane associated (cell surface) β1-integrin expressions of plant extract treated
(10 μg/ml) MCF-7 cells in percent of control measured by flow cytometry. As control DMSO treated cells were used. (mean ± SD, n = 3, **P < 0.01,
*P < 0.05, significantly different compared to control, unpaired t-test). B: Fluorescence microscopy of F-actin (green) alterations after treatment
with 10 μg/ml of the plant extract. Nuclei are marked in blue. Arrows point to the increased actin accumulation at sides of cell-cell contacts.
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Immunotech) was raised against the entire amino acid
sequence, making it more specific for β1-integrin de-
tection. Thus, it is possible that there will be slight dif-
ferences in the recognition of the β1-integrin protein.
Accordingly, the western blot results are only a general
review of the flow cytometry data. However, it could be
confirmed that the ZI extract mediates a clear overex-
pression of β1-integrin in the cell membrane. In contrast,
JCP1 and JCP2 caused a slight reduction in β1-integrin
expression.
Additionally, the expression levels of the focal adhe-
sion kinase (FAK), a widely expressed cytoplasmic pro-
tein tyrosine kinase involved in integrin-mediated signal
transduction and its phosphorylation status was checked
(Figure 3B). Consistent with the lowered β1-integrin ex-
pression levels after treatment with JCP1 and JCP2, the
expression of total FAK and the phosphorylation at resi-
due Tyr397 decreased. Also the exposure to PS caused a
slight decrease in the autophosphorylation of FAK indi-
cating for the deactivation of FAK and lowered adhesion
to the extracellular matrix.
These findings suggest that the plant extracts target
different signaling pathways in the MCF-7 cells and
thus initiate various mechanisms of cell detachment.
Loss of integrin binding to extracellular matrix
proteins results in impairment of cell spreading which
depends on the integrity of the internal actin cytoskel-
eton formation [26]. This assertion is supported by the
fact that the formation of the actin cytoskeleton is af-
fected differently by the plant extracts (Figure 5B).
Under control conditions MCF-7 cells form a diffuse
actin cytoskeleton without any visible stress fibers. The
actin filaments are short and find to be enriched at sides
of cell-cell contacts (Figure 5B; red arrows). JCP1, JCP2
and PS revealed a distinct alteration of the actin
organization. No strong accumulation of actin in adjacent
cells could be observed in comparison with controls.
By treatment with the PS and JCP1 strong cellular
contacts were diminished. Cells seem to be enlarged in
their areas and express filopodia. Consistent with the
increased β1-integrin expression by ZI increased
formation of actin filaments was observed between
neighboring cells (Figure 5B, red arrows). In addition,
the western blot results confirm that after treatment
with JCP1 and JCP2 the β-actin filaments were de-
graded: further evidence for the induction of anoikis
(Figure 3C).However, the three plant extracts (JCP1, JCP2 and PS)
harbor anticancer potential, which should be analyzed in
further studies. Especially the signaling mechanisms
should be identified because initial analysis of central
signaling molecules like the serine/threonine-specific
protein kinase Akt and mitogen-activated protein ki-
nases (MAPKs) showed alterations in their expression
levels (Figure 3C).
Plant extracts harbor IC50 values between 23 and 38 μg/ml
Finally, the IC50 values of the plant extracts for MCF-7
via MTS assay was determined (Figure 6). Data of the
MTS measurements were plotted on dose response
curve and IC50 values were calculated by non-linear re-
gression. The IC50 values for JCP1, PS, ZI and JCP2 for
MCF-7 cells were 36.55, 37.36, 22.76 and 25.55 μg/ml,
respectively. These values describe a moderate potential
as an anti-cancer agent but colorimetric test were not
that convincing and require confirmation by additional
experiments [27]. Also, because the cell cycle analysis,
bright field microscopy and β1-integrin expression
revealed a markedly lower effective concentrations (1–
10 μg/ml) of the plant extracts. However, further investi-
gation is needed to explore the detailed anticancer
potential of these plant extracts and the corresponding
signaling pathways.
Conclusion
Anticancer screening experiments for bioactive agents
from natural products are in focus of current research.
But effective screening methods are rare and sometimes
difficult to interpret. Therefore in this study standard
methods were chosen for the interpretation of the influ-
ence on proliferation (cell cycle measurement, PCNA
expression by Western blotting), apoptosis (cell cycle
measurement, Annexin V/PI labeling, TUNEL assay,
live-dead staining, caspase claevage), morphology (bright
field imaging), metabolism (MTS assay) and adhesion
(β1-integrin expression, F-actin staining, cell detach-
ment). These methods allow an overview of the potential
effectiveness of the extracts on the key mechanisms of
cancer cells, but do not allow a clear identification of
signaling pathways. All four plant extracts displayed dis-
tinct alterations on these major cellular mechanisms in
the breast cancer cell line MCF-7. These results reveal
an anti-tumorigenic potential of the four plant extract.
But the dose response curves and calculated IC50 values
also indicate a general cytotoxic activity. This could be
Figure 6 Determination of IC50 values. The 50% inhibition concentration (IC50) values of the four plant extracts JCP1, PS, ZI, JCP2 on MCF-7
cancer were measured by MTS assay. The four extracts reduced viability of MCF-7 cells in a dose dependent manner. IC50 values (see Table 1)
were calculated from the dose response curves by nonlinear regression. Background absorbance was corrected against MTS reaction without cells
and control treatment (0.1% DMSO).
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Accordingly, in subsequent experiments the active sub-
stance classes will be identified and fractionated. The
overall goal for future work is to isolate the active com-
pounds and their testing on different cancer cell lines.
Interestingly, the PS, JCP1 and JCP2 plant extracts in-
duced cell rounding and cell detachment at concentrations
≥10 μg/ml. Cell detachment could be caused by several
processes. One protein relevant for cancer cell progression
and metastasis is the β1-integrin [28]. This finding impli-
cates that the ZI extracts influences different cellular path-
way compared with other extracts. However, the four
tested plant extracts exert cytotoxic and anticancer poten-
tial which should be investigated in further studies.
In conclusion, the results in the present study coincide
to some extent with the traditional uses of the plants in-
vestigated. Our results further supported the idea that
medicinal plants can be promising sources of potential
anticancer, antimicrobial and antioxidants agents. The
present results will form the basis for selection of plant
species for further investigation in the potential discov-
ery of new natural bioactive compounds. Studies aimed
at the isolation and structure elucidation of anticancer
chemical constituents are in progress.Additional files
Additional file 1: Figure S1. DNA fragmentation by TUNEL assay. Late
apoptotic effects induced by 1 and 10 μg of the four plant extracts on
MCF-7 cells were analyzed by TUNEL assay to measure the extent of DNA
fragmentation visualized by confocal laser scanning microscopy (LSM 780,
Carl Zeiss, Jena, Germany). Green fluorescence within the cell nucleus of PS,
JCP1 and JCP2 (10 μg/ml) reflect DNA damage. Notably, ZI extract causes
cytosolic labeling, an indication for extrinsic apoptotic pathways.
Additional file 2: Figure S2. PCNA and integrin expression by western
blotting. Expression analysis of β1 integrin and Proliferating Cell Nuclear
Antigen (PCNA) of the soluble and membrane fraction of MCF-7 cells
after treatment with 10 μg/ml plant extract in comparison with the
DMSO control. Loading controls were visualized by stain-free imaging of
the SDS-PAGEs prior blotting procedure. Note that β1 integrin expression
is demonstrated twice. Upper panel shows the normal exposure, lower
panel the overexposed variant.Competing interests
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